SSSeth J. Seidman

Seth J. Seidman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seth J. Seidman has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determining EMC Test Levels for Implantable Devices in Bipolar Lead Configuration

    by Seth J. Seidman, Howard I. Bassen

    Certain low-frequency magnetic fields cause interference in implantable medical devices. Electromagnetic compatibility (EMC) standards prescribe injecting voltages into a device under evaluation to simplify testing while approximating or simulating real-world exposure situations to low-frequency magnetic fields. The EMC standard ISO 14117:2012, which covers implantable pacemakers and implantable cardioverter defibrillators (ICDs), specifies test levels for the bipolar configuration of sensing leads as being one-tenth of the levels for the unipolar configuration. The committee authoring this standard questioned this testing level difference and its clinical relevance. To evaluate this issue of EMC test levels, we performed both analytical calculations and computational modeling to determine a basis for this difference. Analytical calculations based upon Faraday's law determined the magnetically induced voltage in a 37.6-cm lead. Induced voltages were studied in a bipolar lead configuration with various spacing between a distal tip electrode and a ring electrode. Voltages induced in this bipolar lead configuration were compared with voltages induced in a unipolar lead configuration. Computational modeling of various lead configurations was performed using electromagnetic field simulation software. The two leads that were insulated, except for the distal and proximal tips, were immersed in a saline-conducting media. The leads were parallel and closely spaced to each other along their length. Both analytical calculations and computational modeling support continued use of a one-tenth amplitude reduction for testing pacemakers and ICDs in bipolar mode. The most recent edition of ISO 14117 includes rationale from this study.


  • 5-GHz Band LTE-LAA Signal Selection for Use as the Unintended Signal in ANSI C63.27 Wireless Coexistence Testing

    by Mohamad Omar Al Kalaa, Seth J. Seidman

    This article details the experimental work conducted at the Electromagnetic Compatibility and Wireless Laboratory, U.S. Food and Drug Administration, to investigate the use of Licensed Assisted Access (LAA) signals for wireless coexistence testing. A software-defined radio platform was deployed to generate realistic LAA signals and measure the wireless coexistence impact on the LAA communication link. The equipment under test (EUT) used IEEE 802.11ac as an example of incumbent technology in the 5-GHz band. The standardized radiated anechoic chamber method was used for testing. Results highlight the mutual coexistence impact of LAA in the 5-GHz band and suggest that selecting an LAA signal with the maximum possible channel time occupancy and the highest possible modulation and coding scheme yields the most impactful coexistence situation on both the EUT and the LAA system. Additionally, an analysis of the internal LAA system states during coexistence testing is presented to document the inverse relationship between LAA transmit and wait times during coexistence and the adverse impact of challenging coexistence scenarios on successful channel access. Finally, the risk management process of wireless coexistence for medical devices is summarized and associated with coexistence testing.


  • An outlook on wireless coexistence with focus on medical devices

    by Mohamad Omar Al Kalaa, Joshua Guag, Seth J. Seidman

    The use of shared and unlicensed radio spectrum has been the impetus of innovative and widely used technologies (e.g., Wi-Fi, Bluetooth, and others) — driving the scene of ubiquitous connectivity for devices, sensors, and peripherals in an encompassing Internet of Things (IoT). However, coexisting technologies operating in unlicensed bands need to share limited spectrum resources while attempting to offer desired performance. This could prove challenging as channel access is not guaranteed, which raises concerns for wireless coexistence in sensitive applications like medical devices. In this article, we provide a brief review of topics forming the current stage of wireless coexistence in research, industry, and regulatory circles. We present the standardization activities for the evaluation of wireless coexistence, and recent advancements of unlicensed spectrum technologies such as Wi-Fi, Bluetooth, and Long Term Evolution (LTE) in unlicensed bands, along with proposed evaluation methods.


  • Open Access

    Feasibility results of an electromagnetic compatibility test protocol to evaluate medical devices to radio frequency identification exposure

    by Seth J Seidman, Omar Bekdash, Joshua Guag, Maryam Mehryar, Paul Booth, Paul Frisch

    The use of radio frequency identification (RFID) systems in healthcare is increasing, and concerns for electromagnetic compatibility (EMC) pose one of the biggest obstacles for widespread adoption. Numerous studies have demonstrated that RFID systems can interfere with medical devices; however, the majority of past studies relied on time-consuming and burdensome test schemes based on ad hoc test methods applied to individual RFID systems. This paper presents the results of using an RFID simulator that allows for faster evaluation of RFID-medical device EMC against a library of RFID test signals at various field strengths. The results of these tests demonstrate the feasibility and adequacy of simulator testing and can be used to support its incorporation into applicable consensus standards. This work can aid the medical device community in better assessing the risks associated with medical device exposure to RFID.


  • Open Access

    Adhoc electromagnetic compatibility testing of non-implantable medical devices and radio frequency identification

    by Seth J Seidman, Joshua W Guag

    The use of radiofrequency identification (RFID) in healthcare is increasing and concerns for electromagnetic compatibility (EMC) pose one of the biggest obstacles for widespread adoption. Numerous studies have documented that RFID can interfere with medical devices. The majority of past studies have concentrated on implantable medical devices such as implantable pacemakers and implantable cardioverter defibrillators (ICDs). This study examined EMC between RFID systems and non-implantable medical devices. Medical devices were exposed to 19 different RFID readers and one RFID active tag. The RFID systems used covered 5 different frequency bands: 125–134 kHz (low frequency (LF)); 13.56 MHz (high frequency (HF)); 433 MHz; 915 MHz (ultra high frequency (UHF])) and 2.4 GHz. We tested three syringe pumps, three infusion pumps, four automatic external defibrillators (AEDs), and one ventilator. The testing procedure is modified from American National Standards Institute (ANSI) C63.18, Recommended Practice for an On-Site, Ad Hoc Test Method for Estimating Radiated Electromagnetic Immunity of Medical Devices to Specific Radio-Frequency Transmitters. For syringe pumps, we observed electromagnetic interference (EMI) during 13 of 60 experiments (22%) at a maximum distance of 59 cm. For infusion pumps, we observed EMI during 10 of 60 experiments (17%) at a maximum distance of 136 cm. For AEDs, we observed EMI during 18 of 75 experiments (24%) at a maximum distance of 51 cm. The majority of the EMI observed was classified as probably clinically significant or left the device inoperable. No EMI was observed for all medical devices tested during exposure to 433 MHz (two readers, one active tag) or 2.4 GHz RFID (two readers). Testing confirms that RFID has the ability to interfere with critical medical equipment. Hospital staff should be aware of the potential for medical device EMI caused by RFID systems and should be encouraged to perform on-site RF immunity tests prior to RFID system deployment or prior to placing new medical devices in an RFID environment. The methods presented in this paper are time-consuming and burdensome and suggest the need for standard test methods for assessing the immunity of medical devices to RFID systems.


  • Open Access

    Wireless Coexistence and EMC of Bluetooth and 802.11b Devices in Controlled Laboratory Settings

    by Seth Seidman, Wolfgang Kainz, Paul Ruggera, Gonzalo Mendoza

    This paper presents experimental testing that has been performed on wireless communication devices as victims of electromagnetic interference (EMI). Wireless victims included universal serial bus (USB) network adapters and personal digital assistants (PDAs) equipped with IEEE 802.11b and Bluetooth technologies. The experimental data in this paper was gathered in an anechoic chamber and a gigahertz transverse electromagnetic (GTEM) cell to ensure reliable and repeatable results. This testing includes: Electromagnetic compatibility (EMC) testing performed in accordance with IEC 60601-1-2, an in-band sweep of EMC testing, and coexistence testing. The tests in this study show that a Bluetooth communication was able to coexist with other Bluetooth devices with no decrease in throughput and no communication breakdowns. However, testing revealed a significant decrease in throughput and increase in communication breakdowns when an 802.11b source is near an 802.11b victim. In a hospital setting decreased throughput and communication breakdowns can cause wireless medical devices to fail. It is therefore vital to have an understanding of the effect EMI can have on wireless communication devices.


  • Open Access

    Electromagnetic compatibility of implantable neurostimulators to RFID emitters

    by Oxana S Pantchenko, Seth J Seidman, Joshua W Guag, Donald M WittersJr, Curt L Sponberg

    The objective of this study is to investigate electromagnetic compatibility (EMC) of implantable neurostimulators with the emissions from radio frequency identification (RFID) emitters. Six active implantable neurostimulators with lead systems were tested for susceptibility to electromagnetic fields generated by 22 RFID emitters. These medical devices have been approved for marketing in the U.S. for a number of intended uses that include: epilepsy, depression, incontinence, Parkinsonian tremor and pain relief. Each RFID emitter had one of the following carrier frequencies: 125 kHz, 134 kHz, 13.56 MHz, 433 MHz, 915 MHz and 2.45 GHz The test results showed the output of one of the implantable neurostimulators was inhibited by 134 kHz RFID emitter at separation distances of 10 cm or less. The output of the same implantable neurostimulator was also inhibited by another 134 kHz RFID emitter at separation distances of 10 cm or less and also showed inconsistent pulsing rate at a separation distance of 15 cm. Both effects occurred during and lasted through out the duration of the exposure. The clinical significance of the effects was assessed by a clinician at the U.S. Food and Drug Administration. The effects were determined to be clinically significant only if they occurred for extended period of time. There were no observed effects from the other 5 implantable neurostimulators or during exposures from other RFID emitters.


  • Open Access

    Analysis of induced electrical currents from magnetic field coupling inside implantable neurostimulator leads

    by Oxana S Pantchenko, Seth J Seidman, Joshua W Guag

    Over the last decade, the number of neurostimulator systems implanted in patients has been rapidly growing. Nearly 50, 000 neurostimulators are implanted worldwide annually. The most common type of implantable neurostimulators is indicated for pain relief. At the same time, commercial use of other electromagnetic technologies is expanding, making electromagnetic interference (EMI) of neurostimulator function an issue of concern. Typically reported sources of neurostimulator EMI include security systems, metal detectors and wireless equipment. When near such sources, patients with implanted neurostimulators have reported adverse events such as shock, pain, and increased stimulation. In recent in vitro studies, radio frequency identification (RFID) technology has been shown to inhibit the stimulation pulse of an implantable neurostimulator system during low frequency exposure at close distances. This could potentially be due to induced electrical currents inside the implantable neurostimulator leads that are caused by magnetic field coupling from the low frequency identification system. To systematically address the concerns posed by EMI, we developed a test platform to assess the interference from coupled magnetic fields on implantable neurostimulator systems. To measure interference, we recorded the output of one implantable neurostimulator, programmed for best therapy threshold settings, when in close proximity to an operating low frequency RFID emitter. The output contained electrical potentials from the neurostimulator system and those induced by EMI from the RFID emitter. We also recorded the output of the same neurostimulator system programmed for best therapy threshold settings without RFID interference. Using the Spatially Extended Nonlinear Node (SENN) model, we compared threshold factors of spinal cord fiber excitation for both recorded outputs. The electric current induced by low frequency RFID emitter was not significant to have a noticeable effect on electrical stimulation. We demonstrated a method for analyzing effects of coupled magnetic field interference on implantable neurostimulator system and its electrodes which could be used by device manufacturers during the design and testing phases of the development process.


  • Open Access

    Electromagnetic Compatibility Testing of Implantable Neurostimulators Exposed to Metal Detectors

    by Seth J Seidman, Wolfgang Kainz, Jon Casamento, Donald Witters

    This paper presents results of electromagnetic compatibility (EMC) testing of three implantable neurostimulators exposed to the magnetic fields emitted from several walk-through and hand-held metal detectors. The motivation behind this testing comes from numerous adverse event reports involving active implantable medical devices (AIMDs) and security systems that have been received by the Food and Drug Administration (FDA). EMC testing was performed using three neurostimulators exposed to the emissions from 12 walk-through metal detectors (WTMDs) and 32 hand-held metal detectors (HHMDs). Emission measurements were performed on all HHMDs and WTMDs and summary data is presented. Results from the EMC testing indicate possible electromagnetic interference (EMI) between one of the neurostimulators and one WTMD and indicate that EMI between the three neurostimulators and HHMDs is unlikely. The results suggest that worst case situations for EMC testing are hard to predict and testing all major medical device modes and setting parameters are necessary to understand and characterize the EMC of AIMDs.